Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | TBI-1301 |
Trade Name | |
Synonyms | mipetresgene autoleucel |
Drug Descriptions |
TBI-1301 is a preparation of T-cells modified to express a T-cell receptor that targets NY-ESO-1, which potentially inhibits tumor growth (J Clin Onc 2019 37:15_suppl, 2537, PMID: 37792433). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C120557 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
TBI-1301 | TBI-1301 | 0 | 1 |